Combined Basal-bolus Insulin and Post-exercise Carbohydrate Feeding Strategy in T1DM
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
The investigators hypothesise that reducing basal insulin dose (Glargine, Lantus,
Sanofi-Aventis, or Detemir, Levemir, Novo Nordisk), whilst employing current carbohydrate
feeding and rapid-acting insulin dose recommendations will protect patients with type 1
diabetes from early- and late-onset hypoglycaemia following evening time exercise.